CORC

在结果中检索

CORC

浏览/检索结果: 共1375条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：15/0  |  提交时间：2023/11/10
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15
作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie
收藏  |  浏览/下载：227/0  |  提交时间：2022/12/23
The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
收藏  |  浏览/下载：13/0  |  提交时间：2022/12/22
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文
LEUKEMIA, 2022
作者:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng
收藏  |  浏览/下载：76/0  |  提交时间：2022/02/14
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载：43/0  |  提交时间：2022/02/14
Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文
CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218
作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan
收藏  |  浏览/下载：53/0  |  提交时间：2021/12/16
CYH33  MYC  P300  BET  B cell lymphoma  PI3K  
Physical characteristics of plasma exosomes from patients with lymphoma based on AFM 期刊论文
生物化学与生物物理进展, 2022, 页码: 1-14
作者:  Li XX(李鑫鑫);  Liu ZH(刘志华);  Wang XL(王鑫磊);  Wang WX(王文学);  Xing XJ(邢晓静)
收藏  |  浏览/下载：26/0  |  提交时间：2022/05/15

©版权所有 ©2017 CSpace - Powered by CSpace